Hahn Wins Senate Backing to Become Trump’s Next FDA Chief

U.S. senators voted overwhelmingly to back President Donald Trump’s nominee to lead the Food and Drug Administration, clearing Stephen Hahn to steer the agency as it deals with pressing health issues including generic-drug safety and vaping regulations.

The Texas oncologist sailed through a Senate Health, Education, Labor, and Pensions committee vote Dec. 3, and the final vote by the full Senate on Thursday was 72 to 18.

Hahn, 59, will likely pick up where predecessor Scott Gottlieb left off, tackling issues such as drug shortages, increasing generic approvals and encouraging alternatives to traditional opioids for pain management. Hahn said during ...